Gossamer Bio Inc (GOSS)
0.7378
0.00 (0.00%)
USD |
NASDAQ |
May 10, 16:00
0.7378
0.00 (0.00%)
After-Hours: 20:00
Gossamer Bio Total Assets (Quarterly): 311.92M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 311.92M |
| September 30, 2023 | 347.92M |
| June 30, 2023 | 181.75M |
| March 31, 2023 | 219.91M |
| December 31, 2022 | 272.45M |
| September 30, 2022 | 323.54M |
| June 30, 2022 | 245.84M |
| March 31, 2022 | 294.68M |
| December 31, 2021 | 343.66M |
| September 30, 2021 | 387.04M |
| June 30, 2021 | 432.51M |
| March 31, 2021 | 482.47M |
| Date | Value |
|---|---|
| December 31, 2020 | 539.43M |
| September 30, 2020 | 584.18M |
| June 30, 2020 | 625.08M |
| March 31, 2020 | 371.48M |
| December 31, 2019 | 426.60M |
| September 30, 2019 | 469.75M |
| June 30, 2019 | 507.17M |
| March 31, 2019 | 515.95M |
| December 31, 2018 | 239.42M |
| September 30, 2018 | 262.18M |
| December 31, 2017 | 0.445M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
181.75M
Minimum
Jun 2023
625.08M
Maximum
Jun 2020
387.76M
Average
371.48M
Median
Mar 2020
Total Assets (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 777.88M |
| TG Therapeutics Inc | 373.32M |
| Replimune Group Inc | 532.93M |
| 89bio Inc | 596.27M |
| Moderna Inc | 16.73B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 249.15M |
| Shareholders Equity (Quarterly) | 62.77M |